Headway has 6 close competitors: StockX, Andela, Ankorstore.
Sector, valuation and status for each competitor.
competitor›
competitor›
competitor›
competitor›
competitor›
competitor›A private valuation and a public market cap share one column; each row names its basis and date.
StockXAndelaAnkorstoreAppDirectBack MarketBluecoreHeadway connects therapists with people and insurance schemes, building a network of in-network mental health providers.
Headway competes with 6 companies here: StockX, Andela, Ankorstore, AppDirect, Back Market, Bluecore.
Headway was last valued at $2.3B (post-money). That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
The routes section explains what is realistically available for a company at this stage.
No. Headway is a private company; its shares do not trade on a public exchange.
The last valuation is $2.3B.
Lead investors for each round are in the funding timeline.
The closest healthcare (mental health / therapist-insurance marketplace) peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
